(L-R) Petra Barker State Manager (NBCF), Samantha Oaks Associate Professor, Director of Research & Investments (NBCF), Jackie Horwill Head of Corporate Partnerships, Ludovic Dellazzeri Managing Director ghd Australia and New Zealand and Colette Peric Head of Salon Sales ghd Australia and New Zealand.
ghd’s annual pink campaigns raising millions for breast cancer research while urging women to ‘take control now’ by regularly checking their breasts was nominated by NBCF and has been recognised by the national peak body for Australian health and medical research, winning the Advocacy Award 2022.
With a consumer base heavily skewed towards younger women who may not be aware of their susceptibility to breast cancer, ghd created a bespoke campaign empowering them to be “breast aware” whilst raising funds for breast cancer research from every Pink purchase.
Recognising their long-term commitment and resulting impact, Research Australia has announced ghd as the winner of the Advocacy category of its national Health and Medical Research Awards.
The Advocacy Award recognises exceptional contributions by an individual or team who has supported Australian communities through championing and raising awareness about the importance of health and medical research. Now in its 18th year of support, ghd has raised more than $4.5M for the National Breast Cancer Foundation in Australia, and over US$22M for breast cancer charities globally.
In the same way that they seek to embed their important message among their target audience, ghd have embellished the ‘Take Control Now’ message on their hair care tools as a reminder to regularly self-check, with $20 from every Pink purchase donated to breast cancer research.
Ludovic Dellazzeri, ghd’s Managing Director Australia and New Zealand said, “We’re absolutely thrilled and honoured to accept this unique recognition from Research Australia for our support towards funding breast cancer research”
“We have long strived to empower women to be breast aware and take action with regular self-checks for early detection, to achieve the objective of a zero-death toll from Breast Cancer. This award is a reminder of the magnitude of our campaign’s impact, and a catalyst for momentum in achieving this goal in the years to come.”
“We are very proud to have received this amazing public recognition in the research arena, particularly considering no other commercial organisation has been granted this accolade since the award’s inception 19 years ago!”
NBCF CEO Associate Professor Cleola Anderiesz said that “ghd has been a valuable partner of the National Breast Cancer Foundation (NBCF) for the past 18 years.”
“In that time, they have raised $4.5 million. Their Take Control Now campaign helps raise awareness of breast cancer in young women whilst raising vital funds for breast cancer research. We were extremely proud to nominate ghd for the 2022 Research Australia Advocacy Award.
“Through their annual pink campaigns, ghd drive awareness of breast cancer and support of the National Breast Cancer Foundation to fund world-class breast cancer research that will help ultimately save lives. This valued and enduring partnership is a testament to our shared commitment to reaching Zero Deaths from breast cancer.”
